Panaxea‘s Iris Boot will present her AutoCRAT work at the November 12th- 15th ISPOR 2023 conference in Copenhagen. The title of Iris’s poster is “Cell-based treatment increases Quality of Life and reduces amount of Knee Replacement Surgeries compared to current standard of care for knee osteoarthritis patients.” Preview the poster here.
In AutoCRAT, Panaxea is focused on the economic evaluation of GMP manufacturing and at-line testing using the AutoCRAT system. ISPOR provides an opportunity for researchers to convene with global healthcare leaders who share their interests in Health Economics and Outcomes Research (HEOR).